Location History:
- Kuching Sarawak, MY (2010 - 2014)
- Georgetown, MY (2018 - 2020)
- Kuala Lumpur, MY (2020)
Company Filing History:
3 out of 3 
2 out of 132 
2 out of 2 Years Active: 2010-2020
Title: The Innovative Contributions of Mary Jane Cardosa in Vaccine Development
Introduction
Mary Jane Cardosa is an accomplished inventor residing in Kuching Sarawak, Malaysia. With two patents under her name, she has made significant contributions to the field of vaccine development, particularly in the realm of Flavivirus research. Her work showcases the intersection of creativity and scientific innovation that is crucial for addressing pressing health challenges.
Latest Patents
Mary Jane Cardosa's most notable inventions include her patents focusing on Flavivirus NS1 subunit vaccines and MVA virus vectors expressing dengue NS1 proteins. The first patent details the NS1 proteins or parts thereof of Flaviviruses, especially Dengue viruses, which are pivotal for vaccinations against various serotypes of these viruses. This invention also involves the development of DNA containing an expression cassette coding for Flavivirus NS1, along with vectors and vaccines that utilize or express this NS1 protein. Similarly, her second patent on the MVA virus vector outlines the same NS1 proteins and their utility in producing effective vaccines against Dengue viruses, showcasing her dedication to improving public health through innovative vaccine solutions.
Career Highlights
Throughout her career, Mary Jane Cardosa has collaborated with reputable companies, including Bavarian Nordic A/S and Venture Technologies Sdn Bhd. Her work in these organizations has significantly enhanced her expertise in vaccine research and development, leading to successful innovations that hold promise for the future of infectious disease management.
Collaborations
Mary Jane has also worked alongside esteemed colleagues, such as Paul Michael Howley and Sonja Leyrer. These collaborations have not only fostered a rich exchange of ideas but have also contributed to the greater success of her patent applications. The synergy developed in these partnerships highlights the importance of teamwork in advancing scientific research.
Conclusion
Mary Jane Cardosa exemplifies the spirit of innovation in the field of vaccine development. With her two patents focusing on combating Flavivirus infections, she is at the forefront of creating solutions that could positively impact global health. Her career, marked by significant collaborations and contributions to prominent companies, underscores her vital role as an inventor in the fight against infectious diseases. As we look toward the future, her work stands as a testament to the power of innovation in improving healthcare outcomes.